ARCHIVES

Broder Says No Thanks To Acknowledgement For Paper’s Title

This article is from The Cancer Letter archive.

Vol. 23 No. 22 | June 6, 1997

Download PDF Visit The Full Archive

Related Articles

FDA Advisors Give Dox-SL Conditional Approval; Ok Zoladex

February 24, 1995

NDA For MeCCNU Turned Down By Oncologic Drugs Advisory Committee

September 3, 1976

Phase III Trial of Talimogene Laherparepvec Meets Response Rate Primary Endpoint

March 29, 2013

In Brief: ACCC Celebrates 25th: James Hospital Receives Large Donations

April 9, 1999

In Brief: Three Scientists Share Nobel Prize For Work In Genetics; Clinton Forms Bioethics Panel

October 13, 1995

NCAB Committee Approves Concepts For Recompetition Of CIDAC, Two Other Contracts

July 1, 1983